Filing Details

Accession Number:
0001209191-21-038769
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-07 20:00:19
Reporting Period:
2021-06-03
Accepted Time:
2021-06-07 20:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1564824 Allakos Inc. ALLK Pharmaceutical Preparations (2834) 454798831
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1637219 Adam Tomasi 975 Island Drive, Suite 201
Redwood City CA 94065
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-07 2,487 $92.03 148,220 No 4 S Direct
Common Stock Disposition 2021-06-04 642 $90.26 150,707 No 4 S Direct
Common Stock Disposition 2021-06-03 1,777 $92.20 151,349 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 F Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,953 Indirect See footnote
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.17 to $92.66 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  2. Includes shares of common stock purchased under the Company's 2018 Employee Stock Purchase Plan.
  3. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020. This transaction was executed in multiple trades at prices ranging from $90.10 to $90.39 per share. The sale price reported represents the weighted average sale price . Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person hereby undertakes to provide full information regarding the number of shares sold at each separate price.
  4. Shares withheld to satisfy the tax obligations by the reporting person in connection with the vesting of RSUs.
  5. Includes 3,953 shares received as a pro-rata in-kind distribution of Common Stock of the Issuer by Alta Partners Management VIII, LLC (APM VIII), without consideration, to the reporting person as a non-managing member of APM VIII.
  6. The shares are held by Mr. Tomasi and Carrie Tomasi, as Trustees of the Tomasi Living Trust dated July 14, 2017.